These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8502506)

  • 1. Antenatal corticosteroids appear to reduce the risk of postnatal germinal matrix hemorrhage in intubated low birth weight newborns.
    Leviton A; Kuban KC; Pagano M; Allred EN; Van Marter L
    Pediatrics; 1993 Jun; 91(6):1083-8. PubMed ID: 8502506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial blood gas derangements associated with death and intracranial hemorrhage in premature babies.
    Skouteli HN; Kuban KC; Leviton A; Brown ER; Krishnamoorthy KS; Pagano M; Allred EN; Sullivan KF; Baglivo JA; Huff KR
    J Perinatol; 1988; 8(4):336-41. PubMed ID: 3236103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal toxemia and neonatal germinal matrix hemorrhage in intubated infants less than 1751 g.
    Leviton A; Kuban KC; Pagano M; Brown ER; Krishnamoorthy KS; Allred EN
    Obstet Gynecol; 1988 Oct; 72(4):571-6. PubMed ID: 3047606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of antenatal corticosteroid administration after preterm premature rupture of the membranes.
    Vermillion ST; Soper DE; Bland ML; Newman RB
    Am J Obstet Gynecol; 2000 Oct; 183(4):925-9. PubMed ID: 11035339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined antenatal vitamin K and phenobarbital therapy for preventing intracranial hemorrhage in newborns less than 34 weeks' gestation.
    Thorp JA; Ferrette-Smith D; Gaston LA; Johnson J; Yeast JD; Meyer B
    Obstet Gynecol; 1995 Jul; 86(1):1-8. PubMed ID: 7784000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal intracranial hemorrhage and phenobarbital.
    Kuban KC; Leviton A; Krishnamoorthy KS; Brown ER; Teele RL; Baglivo JA; Sullivan KF; Huff KR; White S; Cleveland RH
    Pediatrics; 1986 Apr; 77(4):443-50. PubMed ID: 3515304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of phenobarbital on motor activity and intraventricular hemorrhage in preterm infants with respiratory disease weighing less than 1500 grams.
    Porter FL; Marshall RE; Moore JA; Miller RH
    Am J Perinatol; 1985 Apr; 2(2):63-6. PubMed ID: 4096759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of respiratory disorders in neonates born between 34 and 36 weeks of gestation following exposure to antenatal corticosteroids between 24 and 34 weeks of gestation.
    Ventolini G; Neiger R; Mathews L; Adragna N; Belcastro M
    Am J Perinatol; 2008 Feb; 25(2):79-83. PubMed ID: 18188800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it safer to intubate premature infants in the delivery room?
    Aly H; Massaro AN; Patel K; El-Mohandes AA
    Pediatrics; 2005 Jun; 115(6):1660-5. PubMed ID: 15930230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined antenatal corticosteroids and vitamin K therapy for preventing periventricular-intraventricular hemorrhage in premature newborns less than 35 weeks gestation.
    Liu J; Wang Q; Zhao JH; Chen YH; Qin GL
    J Trop Pediatr; 2006 Oct; 52(5):355-9. PubMed ID: 16751657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilirubin, intraventricular hemorrhage, and phenobarbital in very low birth weight babies.
    Epstein MF; Leviton A; Kuban KC; Pagano M; Meltzer C; Skouteli HN; Brown ER; Sullivan KF
    Pediatrics; 1988 Sep; 82(3):350-4. PubMed ID: 3405664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antepartum vitamin K and phenobarbital for preventing intraventricular hemorrhage in the premature newborn: a randomized, double-blind, placebo-controlled trial.
    Thorp JA; Parriott J; Ferrette-Smith D; Meyer BA; Cohen GR; Johnson J
    Obstet Gynecol; 1994 Jan; 83(1):70-6. PubMed ID: 8272312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of the time interval from antenatal corticosteroid exposure to delivery on neonatal outcome of very low birth weight infants.
    Sehdev HM; Abbasi S; Robertson P; Fisher L; Marchiano DA; Gerdes JS; Ludmir J
    Am J Obstet Gynecol; 2004 Oct; 191(4):1409-13. PubMed ID: 15507974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants.
    Modanlou HD; Beharry K; Padilla G; Iriye B
    J Perinatol; 1996; 16(6):422-8; quiz 429-30. PubMed ID: 8979178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study.
    Ring AM; Garland JS; Stafeil BR; Carr MH; Peckman GS; Pircon RA
    Am J Obstet Gynecol; 2007 May; 196(5):457.e1-6. PubMed ID: 17466700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconsideration of head compression and intraventricular hemorrhage in the vertex very-low-birth-weight fetus.
    Welch RA; Bottoms SF
    Obstet Gynecol; 1986 Jul; 68(1):29-34. PubMed ID: 3725256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subependymal and intraventricular hemorrhages in the newborn.
    Leech RW; Kohnen P
    Am J Pathol; 1974 Dec; 77(3):465-75. PubMed ID: 4473900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal betamethasone compared with dexamethasone (betacode trial): a randomized controlled trial.
    Campbell WA
    Obstet Gynecol; 2007 Oct; 110(4):930; author reply 931. PubMed ID: 17906036
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study].
    Fekih M; Chaieb A; Sboui H; Denguezli W; Hidar S; Khairi H
    Tunis Med; 2002 May; 80(5):260-5. PubMed ID: 12534029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
    Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
    Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.